Hyperlipoproteinemia and coronary heart disease (Q39913209)

15 September 2017

1 reference

title

Hyperlipoproteinemia and coronary heart disease (English)

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Cardiology and cardiovascular medicine

2 February 2023

main subject

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

2 February 2023

1

N. J. Stone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4550861

2 February 2023

author name string

R. I. Levy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4550861

2 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4550861

2 February 2023

publication date

1 January 1972

1 reference

full work available at URL

15 September 2017

https://api.elsevier.com/content/article/PII:003306207290031X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

https://api.elsevier.com/content/article/PII:003306207290031X?httpAccept=text/plain

2 February 2023

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Progress in Cardiovascular Diseases

2 February 2023

published in

1 reference

15 September 2017

volume

14

1 reference

15 September 2017

issue

4

1 reference

15 September 2017

page(s)

341-359

1 reference

The concept of precoronary care

15 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Selected risk factors in coronary disease. Possible intervention effects

2 February 2023

4

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

2 February 2023

familial hyperlipidemia

5

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

2 February 2023

6

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders

2 February 2023

7

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

2 February 2023

8

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

2 February 2023

9

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

2 February 2023

10

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Mortality of the foreign born

2 February 2023

11

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Coronary heart disease in seven countries

2 February 2023

14

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Work Activity of Longshoremen as Related to Death from Coronary Heart Disease and Stroke

2 February 2023

15

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Psychologic and social precursors of coronary disease (first of two parts).

2 February 2023

16

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Psychologic and social precursors of coronary disease. (II).

2 February 2023

17

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Prevalence and incidence of coronary heart disease in strata of the labor force of a Chicago industrial corporation

2 February 2023

20

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

THE INTERRELATIONSHIP OF SERUM CHOLESTEROL, HYPERTENSION, BODY WEIGHT, AND RISK OF CORONARY DISEASE. RESULTS OF THE FIRST TEN YEARS' FOLLOW-UP IN THE LOS ANGELES HEART STUDY.

2 February 2023

21

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

A longitudinal study of coronary heart disease

2 February 2023

22

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Acute myocardial infarction in 258 cases of diabetes. Immediate mortality and five-year survival

2 February 2023

23

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Risk Factors in Coronary Artery Disease, Hypertension and Diabetes

2 February 2023

24

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types II, 3, IV, and V hyperlipoproteinemia

2 February 2023

25

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Familial factors in premature coronary heart disease--a preliminary report from the Tecumseh Community Health Study

2 February 2023

26

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study

2 February 2023

27

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

2 February 2023

28

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Joint dependence of risk of coronary heart disease on serum cholesterol and systolic blood pressure: a discriminant function analysis

2 February 2023

29

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Serum lipids, hypertension and coronary artery disease

2 February 2023

30

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Serum triglycerides in health and in ischemic heart disease

2 February 2023

31

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Hyperglycemia and Hypertriglyceridemia Among Persons with Coronary Heart Disease

2 February 2023

32

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Serum Insulin, Carbohydrate, and Lipid Abnormalities in Patients with Premature Coronary Heart Disease

2 February 2023

33

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Lipoproteins, aging, and coronary artery disease

2 February 2023

34

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Practical methods for plasma lipoprotein analysis

2 February 2023

35

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons

2 February 2023

38

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins

2 February 2023

39

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Mechanisms involved in hyperlipidemia

2 February 2023

41

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Atherosclerosis and aortic stenosis in hypercholesteremic xanthomatosis

2 February 2023

46

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Coronary Disease in Familial Hypercholesterolemia

2 February 2023

47

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states

2 February 2023

49

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

The dietary management of hyperlipoproteinemia

2 February 2023

50

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Serum cholesterol response to changes in the diet: IV. Particular saturated fatty acids in the diet

2 February 2023

51

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Hypolipidemic drugs and hyperlipoproteinemia

2 February 2023

52

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.

2 February 2023

54

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Cholestyramine therapy in patients homozygous for familial hypercholesterolemia (familial hypercholesterolemic xanthomatosis).

2 February 2023

55

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Lipoprotein lipid alterations with cholestyramine administration

2 February 2023

56

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Influence of thyroid hormones and related compounds on cholesterol biosynthesis and degradation: a review

2 February 2023

58

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE

2 February 2023

60

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Reduction of serum cholesterol by sodium dextrothyroxine in euthyroid subjects

2 February 2023

61

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

PERSISTENCE OF THE INHIBITORY EFFECT OF NICOTINIC ACID ON CATECHOLAMINE-STIMULATED LIPID MOBILIZATION DURING PROLONGED TREATMENT WITH NICOTINIC ACID

2 February 2023

65

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Treatment of hypercholesteremia by nicotinic acid. Progress report with review of studies regarding mechanism of action

2 February 2023

67

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

The Current Status of Hypolipidemic Drugs

2 February 2023

68

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

On thelipoprotein abnormality in type 3 hyperlipoproteinemia

2 February 2023

70

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Acute Muscular Syndrome Associated with Administration of Clofibrate

2 February 2023

71

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Effects of hyperlipoproteinemias and their treatment on the peripheral circulation

2 February 2023

72

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Role of Insulin in Endogenous Hypertriglyceridemia*

2 February 2023

73

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets

2 February 2023

74

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease

2 February 2023

76

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Ischemic heart disease in young adults. Metabolic and angiographic diagnosis and the prevalence of type IV hyperlipoproteinemia

2 February 2023

77

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Current metabolic-genetic interrelationship in human atherosclerosis, with therapeutic considerations

2 February 2023

78

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Familial type IV hyperlipoproteinemia.

2 February 2023

79

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

2 February 2023

Warfarin therapy. 2.

80

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Clofibrate-induced ventricular arrhythmia

2 February 2023

81

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Dextrothyroxine for lowering serum cholesterol. Analysis of data on 6066 patients

2 February 2023

82

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Alteration of oral digitoxin toxicity and its in vitro binding by cholestyramine

2 February 2023

83

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Lipoprotein patterns in myocardial infarction; relationship between the components identified by paper electrophoresis and in the ultracentrifuge

2 February 2023

84

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

SERUM LIPIDS DURING THE COURSE OF AN ACUTE MYOCARDIAL INFARCTION AND ONE YEAR AFTERWARDS

2 February 2023

85

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

Influence of myocardial infarction on plasma-lipoprotein concentration

2 February 2023

86

1 reference

https://api.crossref.org/works/10.1016/0033-0620(72)90031-X

2 February 2023

Identifiers

1 reference

15 September 2017

1 reference